← Current compounder rows

Current NDC auxiliary source row compounder:2332

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
82396-501
Product Ndc
82396-501
Product Ndc Digits
82396501
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Nicotinamide Adenine Dinucleotide
Proprietary Name Suffix
[empty]
Nonproprietary Name
Nicotinamide Adenine Dinucleotide
Dosage Form Name
INJECTION, SOLUTION
Route Name
INTRAVENOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
ANNOVEX PHARMA, INC.
Establishment Name
ANNOVEX PHARMA, INC.
Establishment Fei
[empty]
Substance Name
NICOTINAMIDE ADENINE DINUCLEOTIDE
Active Ingredients Info
200 mg/1 mL
History Active Ingredients Raw
NICOTINAMIDE ADENINE DINUCLEOTIDE
History Active Ingredients Info Raw
200 mg/1 mL
History Dosage Raw
INJECTION, SOLUTION
Dea Schedule
[empty]
Package Ndc Raw
82396-501-10
Package Ndc
82396-501-10
Package Ndc Digits
8239650110
Package Ndc11
82396050110
Package Description
1 mL in 1 VIAL, GLASS (82396-501-10)
Reporting Period Raw
2025-2
Reporting Period
2025-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:2332
Source Row Number
2332
Source Row Hash
80fe783bbecbf574a611b1cdfe1d09c53c75a7469a54793fb9658463cc655235
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "82396-501",
    "DEASCHEDULE": "",
    "LABELERNAME": "ANNOVEX PHARMA, INC.",
    "SUBSTANCENAME": "NICOTINAMIDE ADENINE DINUCLEOTIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "82396-501-10",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Nicotinamide Adenine Dinucleotide",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Nicotinamide Adenine Dinucleotide",
    "PACKAGEDESCRIPTION": "1 mL in 1 VIAL, GLASS (82396-501-10) ",
    "ACTIVEINGREDIENTSINFO": "200 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:2332
Source Row Number
2332
Status Scope
package
Lookup Ndc
82396-501-10
Lookup Ndc Digits
8239650110
Product Ndc
82396-501
Product Ndc Digits
82396501
Package Ndc
82396-501-10
Package Ndc Digits
8239650110
Package Ndc11
82396050110
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2025-2
Reporting Period
2025-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
80fe783bbecbf574a611b1cdfe1d09c53c75a7469a54793fb9658463cc655235
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45